サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413855

アスパラギン市場：タイプ別、用途別-2024-2030年の世界予測

Asparagine Market by Type (Asparagine Anhydrous, Asparagine Monohydrate), Application (Food & Beverage, Pharmaceutical) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 183 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アスパラギン市場：タイプ別、用途別-2024-2030年の世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アスパラギン市場規模は2023年に118億1,000万米ドルと推計され、2024年には124億米ドルに達し、CAGR 5.29%で2030年には169億6,000万米ドルに達すると予測されます。

アスパラギンの世界市場

主な市場の統計
基準年[2023］ 118億1,000万米ドル
予測年[2024] 124億米ドル
予測年 [2030] 169億6,000万米ドル
CAGR（%） 5.29%
アスパラギン Market-IMG1

アミノ酸の一種であるアスパラギンは、タンパク質の生合成において基本的な役割を果たします。脳の発達と機能に必要不可欠な成分であり、神経伝達物質の前駆体でもあります。アスパラギン市場は、バイオテクノロジー、飲食品、医薬品、動物飼料など様々な産業にまたがっており、その幅広い利用スペクトルを示しています。市場を分析するには、その用途、最終用途、市場規模、成長機会要因、限界、技術革新の可能性などについての洞察が必要です。栄養補助食品に対する健康志向の高まりと製薬業界における研究開発投資の増加が市場成長の原動力となっています。飲食品業界における継続的な技術革新も市場を推進しています。原材料価格の変動、アスパラギンの使用に関する厳しい規制や基準が市場の成長を制限しています。アスパラギンを含む新規医薬製剤の市場開拓、精密医療と標的療法の台頭は、市場に機会をもたらすと予想されます。

地域別の洞察

南北アメリカのアスパラギン市場は、特に北米でバイオテクノロジー分野が進んでいることが特徴です。米国では、主に医薬品と食品産業向けにアスパラギンが生産・消費されています。南米市場は台頭しつつあり、ブラジルは食品添加物用途や研究でアスパラギンの需要が増加しています。北米の食品添加物や臨床栄養に関する厳しい規制が、高純度アスパラギンの需要を後押ししています。中国、日本、インドが主導するアジア太平洋は、医薬品、食品、飲食品産業の成長によりアスパラギン市場が急速に拡大しています。中国の大規模な製造能力は、国内および世界のアスパラギンの重要なサプライヤーとなっています。同地域では、栄養と健康補助食品分野が成長しており、アスパラギンのようなアミノ酸のニーズを牽引しています。規制状況の進化と消費者の健康意識の高まりが、市場力学をさらに形成しています。EMEA（欧州・中東・アフリカ）では、欧州がアスパラギンの成熟市場でリードしており、特に製薬業界や栄養補助食品業界において顕著です。着実に進む高齢化は、アスパラギンを含む栄養補助食品と非経口栄養剤に対する同地域の大きな需要に寄与しています。中東・アフリカ市場は開拓が必要であるが、健康意識の高まりと食生活の変化により成長の可能性を秘めています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはアスパラギン市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、アスパラギン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-アスパラギン市場の市場規模および予測は？

2-アスパラギン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-アスパラギン市場における技術動向と規制の枠組みは？

4-アスパラギン市場における主要ベンダーの市場シェアは？

5-アスパラギン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 健康志向の高まりと栄養補助食品の需要
      • 製薬業界の研究開発投資の増加
      • 食品および飲料業界で続くイノベーション
    • 抑制要因
      • 原材料価格の変動
    • 機会
      • アスパラギンを含む新規医薬製剤の開発。
      • 精密医療と標的療法の台頭
    • 課題
      • アスパラギンの使用に関する厳格な規制と基準
  • 市場セグメンテーション分析
    • タイプ：ドライブレンド栄養製剤における無水アスパラギンの需要の増大
    • アプリケーション：製品の栄養価と風味プロファイルを強化するためのアスパラギンの使用の増加
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 アスパラギン市場：タイプ別

  • アスパラギン無水
  • アスパラギン一水和物

第7章 アスパラギン市場：用途別

  • 飲食品
  • 医薬品

第8章 南北アメリカのアスパラギン市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のアスパラギン市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのアスパラギン市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 契約、コラボレーション、パートナーシップ
    • 受賞・表彰・拡大

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • BioVendor Group
    • Creative Enzymes
    • Duchefa Biochemie B.V.
    • Jazz Pharmaceuticals, Inc.
    • LGC Limited
    • medac GmbH
    • Merck KGaA
    • MP Biomedicals, LLC
    • Porton Biopharma Limited
    • Taj Pharmaceuticals Ltd.
    • Tokyo Chemical Industry（India）Pvt. Ltd.
    • VWR International, LLC
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ASPARAGINE MARKET RESEARCH PROCESS
  • FIGURE 2. ASPARAGINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ASPARAGINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ASPARAGINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ASPARAGINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ASPARAGINE MARKET DYNAMICS
  • FIGURE 7. ASPARAGINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ASPARAGINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ASPARAGINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ASPARAGINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ASPARAGINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ASPARAGINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASPARAGINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ASPARAGINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ASPARAGINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ASPARAGINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ASPARAGINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ASPARAGINE MARKET SIZE, BY ASPARAGINE ANHYDROUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ASPARAGINE MARKET SIZE, BY ASPARAGINE MONOHYDRATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. ASPARAGINE MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ASPARAGINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ASPARAGINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ASPARAGINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ASPARAGINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 98. ASPARAGINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 99. ASPARAGINE MARKET LICENSE & PRICING
目次
Product Code: MRR-C1290E70D508

[183 Pages Report] The Asparagine Market size was estimated at USD 11.81 billion in 2023 and expected to reach USD 12.40 billion in 2024, at a CAGR 5.29% to reach USD 16.96 billion by 2030.

Global Asparagine Market

KEY MARKET STATISTICS
Base Year [2023] USD 11.81 billion
Estimated Year [2024] USD 12.40 billion
Forecast Year [2030] USD 16.96 billion
CAGR (%) 5.29%
Asparagine Market - IMG1

Asparagine, an amino acid, plays a fundamental role in the biosynthesis of proteins. It is an essential component required for the development and functioning of the brain and is a precursor to neurotransmitters. The asparagine market spans various industries, including biotechnology, food and beverage, pharmaceuticals, and animal feed, showcasing its broad spectrum of utilizations. Analyzing the market requires insights into its applications, end-uses, market scope, growth opportunity factors, limitations, and potential areas of innovation. Rising health consciousness for dietary supplements and increased investment in R&D in the pharmaceutical industry are driving the market growth. Ongoing innovations in the food and beverage industry are also propelling the market. Fluctuations in the prices of raw materials and stringent regulations and standards regarding the use of asparagine are restricting market growth. The development of novel pharmaceutical formulations containing asparagine and the rise in precision medicine and targeted therapies are expected to create opportunities in the market.

Regional Insights

The Asparagine market in the Americas is characterized by advanced biotechnology sectors, particularly in North America. The United States produces and consumes Asparagine, predominantly for the pharmaceuticals and food industries. South America's market is emerging, with Brazil showing increasing demand for Asparagine in food additive applications and research. Stringent regulations on North American food additives and clinical nutrition bolster the demand for high-purity Asparagine. The Asia-Pacific, led by China, Japan, and India, has a rapidly expanding asparagine market due to its growing pharmaceutical, food, and beverage industries. China's large-scale manufacturing capabilities make it a significant supplier of Asparagine domestically and globally. The region is witnessing growth in nutrition and health supplement sectors, driving the need for amino acids such as Asparagine. The evolving regulatory landscape and increasing consumer health consciousness further shape the market dynamics. In EMEA, Europe leads with a mature market for Asparagine, particularly within the pharmaceutical and nutraceutical industries. The steadily aging population contributes to the region's significant demand for dietary supplements and parenteral nutrition, which includes Asparagine. The market needs to be developed in the Middle East and Africa but presents potential for growth with rising health awareness and changing dietary habits.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Asparagine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Asparagine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Asparagine Market, highlighting leading vendors and their innovative profiles. These include BioVendor Group, Creative Enzymes, Duchefa Biochemie B.V., Jazz Pharmaceuticals, Inc., LGC Limited, medac GmbH, Merck KGaA, MP Biomedicals, LLC, Porton Biopharma Limited, Taj Pharmaceuticals Ltd., Tokyo Chemical Industry (India) Pvt. Ltd., and VWR International, LLC.

Market Segmentation & Coverage

This research report categorizes the Asparagine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Asparagine Anhydrous
    • Asparagine Monohydrate
  • Application
    • Food & Beverage
    • Pharmaceutical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Asparagine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Asparagine Market?

3. What are the technology trends and regulatory frameworks in the Asparagine Market?

4. What is the market share of the leading vendors in the Asparagine Market?

5. Which modes and strategic moves are suitable for entering the Asparagine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Asparagine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising health consciousness and demand for dietary supplements
      • 5.1.1.2. Increased investment for R&D in pharmaceutical industry
      • 5.1.1.3. Ongoing innovations in the food and beverage industry
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuations in prices of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of novel pharmaceutical formulations containing asparagine.
      • 5.1.3.2. Rise in precision medicine and targeted therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and standards regarding the use of asparagine
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type:Growing demand for Anhydrous asparagine in dry-blending nutritional formulations
    • 5.2.2. Application: Rising usage of Asparagine for enhancing nutritional value and flavor profiles of products
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Asparagine Market, by Type

  • 6.1. Introduction
  • 6.2. Asparagine Anhydrous
  • 6.3. Asparagine Monohydrate

7. Asparagine Market, by Application

  • 7.1. Introduction
  • 7.2. Food & Beverage
  • 7.3. Pharmaceutical

8. Americas Asparagine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Asparagine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Asparagine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player
    • 11.3.1. Agreement, Collaboration, & Partnership
      • 11.3.1.1. Kaimisi New Material and Bicells to build 2,000 t per year L-asparagine project and 100 t per year GABA project
    • 11.3.2. Award, Recognition, & Expansion
      • 11.3.2.1. Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. BioVendor Group
    • 12.1.2. Creative Enzymes
    • 12.1.3. Duchefa Biochemie B.V.
    • 12.1.4. Jazz Pharmaceuticals, Inc.
    • 12.1.5. LGC Limited
    • 12.1.6. medac GmbH
    • 12.1.7. Merck KGaA
    • 12.1.8. MP Biomedicals, LLC
    • 12.1.9. Porton Biopharma Limited
    • 12.1.10. Taj Pharmaceuticals Ltd.
    • 12.1.11. Tokyo Chemical Industry (India) Pvt. Ltd.
    • 12.1.12. VWR International, LLC
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing